As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, enhanced target specificity, and next-generation approaches to target discovery.

Conferences Include:

January 8-9

Recombinant Protein Therapeutics

January 9-10

Enhancing Antibody Binding and Specificity

January 11-12

Emerging Technologies for Antibody Discovery